News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ben Westphalen: Revolutionary way of creating access to molecularly guided treatment options
May 27, 2024, 04:49

Ben Westphalen: Revolutionary way of creating access to molecularly guided treatment options

Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO,  shared on X:         ,

“The Dutch Drug Rediscovery Protocol (DRUP) trial is a revolutionary way of creating access to molecularly guided treatment options for patients with cancer.

Updated information out in Acta Oncologica.“

Source: Ben Westphalen/X

Acta Oncologica Ben Westphalen cancer clinical trial Drug Rediscovery Protocol DRUP DRUP trial ESMO molecularly guided treatment OncoDaily Oncology Precision Oncology
Insight
Aug 18, 2024, 16:02
Isaac Kohane: AI can be the Great Leveller for cancer care
Insight
Aug 18, 2024, 15:58
SIOP Programs Update - July 2024
Insight
Aug 18, 2024, 15:54
Andrea Maliachi: The p value, its limitations and misleading use in medical research
Insight
Aug 18, 2024, 15:44
Amanda Nickles Fader: It’s a great time to become a FWC scholar
Blog
Aug 18, 2024, 15:27
Cheng Ean Chee: Privileged to co-chair the HCC session at the Singapore Hepatology Conference
Blog
Aug 18, 2024, 15:24
Aruni Ghose: The Best Team that I’ve worked with when it comes to Cancer Reach and Coverage
Blog
Aug 18, 2024, 15:17
EM Oncology team participating in ESMO 24 - Dr. Reddy's Laboratories
Blog
Aug 18, 2024, 15:16
CCR researchers have created a massive data resource for treating lung cancer - NCI Center for Cancer Research
Blog
Aug 18, 2024, 15:13
Modupe Elebute-Odunsi: Community Engagement to Increase Cancer Prevention Awareness
Blog
Aug 18, 2024, 15:10
Sami Mansfield: An excellent read from our UK colleagues about cancer risks and prevention
Blog
Aug 18, 2024, 15:09
Hil Moss: Cancer risk in Gen X/Millennials is both harrowing and a critical read
Blog
Aug 18, 2024, 15:03
Jorge Cortes: Olutasidenib among patients with R/R AML mIDH1 previously treated with venetoclax